Daily Halftime Update: NVDA gapped up on this morning's session to retest it's ATHs at $152.89 which was tested back in Nov 21, 2024. Looking for a entry between $149.5-$149.95 (Target: $149.73) and a close above $148.98 for confirmation of Continuation to retest those ATHs in the weeks to come. Looking for a $160 Price Target on the Long Trade here.
免责声明
这些信息和出版物并非旨在提供，也不构成TradingView提供或认可的任何形式的财务、投资、交易或其他类型的建议或推荐。请阅读使用条款了解更多信息。
免责声明
这些信息和出版物并非旨在提供，也不构成TradingView提供或认可的任何形式的财务、投资、交易或其他类型的建议或推荐。请阅读使用条款了解更多信息。